不孕治療藥的全球市場規模調查&預測:藥物類別，終端用戶，流通管道，地區分析，2022-2029年

所謂不孕治療藥是一組用於治療不孕症和改善生殖功能的藥物。

由於醫療保健意識的提高、女性老齡化以及患有壓力和生活方式相關疾病的男女比例增加，預計生育藥物市場將顯著擴大。

本調查的目的是定義近年來各個細分市場和國家的市場規模，並在未來幾年預測它們的價值。本報告設計內容涵蓋調查對像國家產業的定性和定量雙方面。

此外也提供市場未來性的成長促進因素和課題等重要方面相關之詳細資訊。再加上主要企業的競爭情形和提供產品之詳細分析，並涵括利害關係者投資所需的微觀市場潛在機會。詳細的市場區隔和子區隔如下列。

各藥物類別

促性腺激素

芳香酶抑制劑

選擇性雌激素受體調節(SERMs)

雙胍

其他的藥物類別

各終端用戶

男性

女性

各銷售管道

醫院內藥局

零售店

其他的流通管道

各地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

義大利

其他歐洲

亞太地區

中國

印度

日本

澳洲

韓國

其他亞太地區

南美

巴西

墨西哥

全球其他地區

目錄

第1章 摘要整理

• 市場概述
• 世界·各分類市場估計·預測，2019-2029年
  • 不孕治療藥市場(各地區):2019-2029年
  • 不孕治療藥市場(各藥物類別):2019-2029年
  • 不孕治療藥市場:各終端用戶，2019-2029年
  • 不孕治療藥市場:各流通管道，2019-2029年
• 主要趨勢
• 調查手法的介紹
• 調查前提條件

第2章 不孕治療藥的全球市場:定義和範圍

• 調查的目的
• 市場定義和範圍
  • 調查目標範圍
  • 產業的演進
• 調查對像年
• 貨幣換算比率

第3章 不孕治療藥的全球市場動態

• 不孕治療藥市場影響分析(2019-2029年)
  • 推動市場要素
  • 市場課題
  • 市場機會

第4章 不孕治療藥的全球市場:產業分析

• 波特的5力模式
  • 供給企業談判力
  • 買方議價能力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係
• 波特五力分析的未來性方法(2019-2029年)
• PEST分析
  • 政治
  • 經濟
  • 社會
  • 技術性
• 投資採用模式
• 分析師的結論·建議
• 頂級投資機會
• 主要成功策略

第5章 風險評估:COVID-19衝擊

• COVID-19對產業帶來的整體影響的評估
• COVID-19以前和COVID-19以後的市場情景

第6章 不孕治療藥的全球市場:各藥物類別

• 市場概述
• 不孕治療藥的全球市場:各藥物類別，業績-潛在力分析
• 不孕治療藥的全球市場，各藥物類別估計·預測2019-2029
• 不孕治療藥市場，子區隔分析
  • 促性腺激素
  • 芳香酶抑制劑
  • 選擇性雌激素受體調節(SERMs)
  • 雙胍
  • 其他的藥物類別

第7章 不孕治療藥的全球市場:各終端用戶

• 市場概述
• 不孕治療藥的全球市場:各終端用戶實際成果-潛在力分析
• 不孕治療藥的全球市場，各終端用戶估計·預測2019-2029
• 不孕治療藥市場，子區隔分析
  • 男性
  • 女性

第8章 不孕治療藥的全球市場:各流通管道

• 市場概述
• 不孕治療藥的全球市場:各流通管道實際成果-潛在力分析
• 不孕治療藥的全球市場，各流通管道估計·預測(2019-2029年
• 不孕治療藥市場，子區隔分析
  • 醫院內藥局
  • 零售藥局
  • 其他的流通管道

第9章 不孕治療藥的全球市場:各地區分析

• 不孕治療藥的市場，各地區市場概述
• 北美
  • 美國
    • 各藥物類別的估計·預測，2019年～2029年
    • 各終端用戶的估計·預測，2019年～2029年
    • 各流通管道的估計·預測，2019年～2029年
  • 加拿大
• 歐洲的不孕治療藥市場概述
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 其他的歐洲地區
• 亞太地區的不孕治療藥市場概述
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他亞太地區
• 南美的不孕治療藥市場概述
  • 巴西
  • 墨西哥
• 全球其他地區

第10章 競爭資訊

• 頂級市場策略
• 企業簡介
  • Teva Pharmaceuticals Industries
    • 主要的資訊
    • 概要
    • 財務(視資料可得性)
    • 產品概要
    • 最近的開發情形
  • Abbott Laboratories
  • Mankind Pharma
  • Merck KGaA
  • Ferring Pharmaceuticals Inc.
  • Novartis International AG
  • Livzon
  • Pfizer Inc.
  • Theramex
  • Bayer AG

第11章 調查流程

• 調查流程
  • 資料探勘
  • 分析
  • 市場估計
  • 驗證
  • 出版
• 調查屬性
• 調查前提條件

Global Infertility Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2022-2029. The term "infertility medicines" refers to a group of pharmaceuticals that are used to treat infertility and improve a person's reproductive health. They can be swallowed or administered intravenously. Gonadotrophins, dopamine agonists, aromatase inhibitors, biguanides, ovulatory stimulants, selective oestrogen receptor modulators (SERMs), and tricyclic antidepressants are a few of the medications that are frequently used to treat infertility. The infertility drugs market is anticipated to expand significantly owing to upsurge in Healthcare Awareness along with increasing aging female population and growing prevalence of stress and life-style disorders among men and women.

The National Center for Drug Abuse Statistics found that during the COVID-19 lockdowns, almost 60.0% of Americans increased their alcohol intake. In a similar vein, according to a study issued by the World Health Organization in 2021, China had more than 300.0 million smokers, or over one-third of the world's population at the time. In China, there were around 26.6% of adults who smoked who were 15 years of age or older. One of the major contributors to hormonal imbalance, polycystic ovarian disease, and weight problems, which have an immediate influence on the embryo and might cause infertility concerns, is a healthy lifestyle. On the other side, over the past 16 years, the percentage of males with a normal total motile sperm count has decreased by around 10%. The evidence is clear: Men today generate less and less healthy sperm than in the past. However, strict regulatory structure that impedes the approval of products stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Infertility Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to menopausal disorders and high concentration of market players or manufacturer's presence. However, Asia Pacific expected to be the fastest growing region owing to rising healthcare expenditures and initiatives by the government to increase the availability of the infertility treatment in the developing nations.

Major market players included in this report are:

Abbott Laboratories

Ferring Pharmaceuticals Inc.

Merck KGaA

Pfizer Inc.

Novartis International AG

Bayer AG

Theramex

Mankind Pharma

Teva Pharmaceuticals Industries

Livzon

Recent Developments in the Market:

• In order to sell Genea Biomedx's (Australia) fertility products in the US and Canada, Genea Biomedx (Australia) partnered with Hamilton Thorne in 2020.
• In August 2021, Merck introduced Pergoveris Pen in India for the treatment of infertility. The Pergoveris Pen is the first item to ever include both recombinant follicle-stimulating hormone and recombinant luteinizing hormone in a ready-to-use, IVF specialist-prescribed device. A pen with bulk technology that has received international approval offers infertile couples a more secure self-service infertility option.

Global Infertility Drugs Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug class, End User, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Gonadotrophins

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Biguanides

Other Drug Classes

By End User:

Male

Female

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Other Distribution Channels

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Infertility Drugs Market, by region, 2019-2029 (USD Billion)
  • 1.2.2. Infertility Drugs Market, by Drug Class, 2019-2029 (USD Billion)
  • 1.2.3. Infertility Drugs Market, by End User, 2019-2029 (USD Billion)
  • 1.2.4. Infertility Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Infertility Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Infertility Drugs Market Dynamics

• 3.1. Infertility Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Upsurge in Healthcare Awareness along with Increasing Aging Female Population
    • 3.1.1.2. Growing Prevalence of Stress and Life-style Disorders among Men and Women
  • 3.1.2. Market Challenges
    • 3.1.2.1. Strict Regulatory Structure that Impedes the Approval of Products
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising incidences of infertility and miscarriage
    • 3.1.3.2. Increasing public funding for developing these drugs

Chapter 4. Global Infertility Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Infertility Drugs Market, by Drug Class

• 6.1. Market Snapshot
• 6.2. Global Infertility Drugs Market by Drug Class, Performance - Potential Analysis
• 6.3. Global Infertility Drugs Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
• 6.4. Infertility Drugs Market, Sub Segment Analysis
  • 6.4.1. Gonadotrophins
  • 6.4.2. Aromatase Inhibitors
  • 6.4.3. Selective Estrogen Receptor Modulators (SERMs)
  • 6.4.4. Biguanides
  • 6.4.5. Other Drug Classes

Chapter 7. Global Infertility Drugs Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Infertility Drugs Market by End User, Performance - Potential Analysis
• 7.3. Global Infertility Drugs Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
• 7.4. Infertility Drugs Market, Sub Segment Analysis
  • 7.4.1. Male
  • 7.4.2. Female

Chapter 8. Global Infertility Drugs Market, by Distribution Channel

• 8.1. Market Snapshot
• 8.2. Global Infertility Drugs Market by Distribution Channel, Performance - Potential Analysis
• 8.3. Global Infertility Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 8.4. Infertility Drugs Market, Sub Segment Analysis
  • 8.4.1. Hospital Pharmacies
  • 8.4.2. Retail Pharmacies
  • 8.4.3. Other Distribution Channels

Chapter 9. Global Infertility Drugs Market, Regional Analysis

• 9.1. Infertility Drugs Market, Regional Market Snapshot
• 9.2. North America Infertility Drugs Market
  • 9.2.1. U.S. Infertility Drugs Market
    • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. End User breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Infertility Drugs Market
• 9.3. Europe Infertility Drugs Market Snapshot
  • 9.3.1. U.K. Infertility Drugs Market
  • 9.3.2. Germany Infertility Drugs Market
  • 9.3.3. France Infertility Drugs Market
  • 9.3.4. Spain Infertility Drugs Market
  • 9.3.5. Italy Infertility Drugs Market
  • 9.3.6. Rest of Europe Infertility Drugs Market
• 9.4. Asia-Pacific Infertility Drugs Market Snapshot
  • 9.4.1. China Infertility Drugs Market
  • 9.4.2. India Infertility Drugs Market
  • 9.4.3. Japan Infertility Drugs Market
  • 9.4.4. Australia Infertility Drugs Market
  • 9.4.5. South Korea Infertility Drugs Market
  • 9.4.6. Rest of Asia Pacific Infertility Drugs Market
• 9.5. Latin America Infertility Drugs Market Snapshot
  • 9.5.1. Brazil Infertility Drugs Market
  • 9.5.2. Mexico Infertility Drugs Market
• 9.6. Rest of The World Infertility Drugs Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Teva Pharmaceuticals Industries
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Abbott Laboratories
  • 10.2.3. Mankind Pharma
  • 10.2.4. Merck KGaA
  • 10.2.5. Ferring Pharmaceuticals Inc.
  • 10.2.6. Novartis International AG
  • 10.2.7. Livzon
  • 10.2.8. Pfizer Inc.
  • 10.2.9. Theramex
  • 10.2.10. Bayer AG

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Infertility Drugs Market, report scope
• TABLE 2. Global Infertility Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Infertility Drugs Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
• TABLE 4. Global Infertility Drugs Market estimates & forecasts by End User 2019-2029 (USD Billion)
• TABLE 5. Global Infertility Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 6. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Infertility Drugs Market
• TABLE 71. List of primary sources, used in the study of global Infertility Drugs Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Infertility Drugs Market, research methodology
• FIG 2. Global Infertility Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Infertility Drugs Market, key trends 2021
• FIG 5. Global Infertility Drugs Market, growth prospects 2022-2029
• FIG 6. Global Infertility Drugs Market, porters 5 force model
• FIG 7. Global Infertility Drugs Market, pest analysis
• FIG 8. Global Infertility Drugs Market, value chain analysis
• FIG 9. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Infertility Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Infertility Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable